CG
ARA

Cutler Group’s American Renal Associates Holdings, Inc ARA Stock Holding History

Cutler Group’s Portfolio ARA Stock Details ARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,200
Closed -$5K – 4893
2018
Q3 		$5K Buy
+3,200
New +$60.6K ﹤0.01% 3114

Other funds holding ARA

CP
Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WIC
Whitegate Investment Counselors Concord, New Hampshire $315M AUM 10.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cutler Group's ARA Position: Q4 2019 in Review

Cutler Group sold out of American Renal Associates Holdings, Inc (ARA) in Q4 2019, closing a stake of 100 shares.

Cutler Group first reported a position in ARA in Q3 2017 and held it in 3 quarters. The position peaked at $8K in Q4 2017. 66 funds tracked by Wall St. Rank hold ARA as of Q4 2019.

  • Cutler Group reported no remaining American Renal Associates Holdings, Inc position as of Q4 2019 after selling out during the quarter.
  • Cutler Group sold 100 American Renal Associates Holdings, Inc shares in Q4 2019.
  • Cutler Group first reported a position in American Renal Associates Holdings, Inc in Q3 2017 and held it in 3 quarters.
  • Cutler Group's American Renal Associates Holdings, Inc position peaked at $8K in Q4 2017.
  • 66 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q4 2019.

Based on Cutler Group's 13F filing for Q4 2019, filed 6 Feb 2020.